Maybe TGR went too far too soon and corrected earlier but there was a very long and deep correction for the sector which hasn't finished yet. More likely, a takeover was opportunistic and taking advantage of the lower sp rather than the cause of the lower sp. TGR peaked in mid 2021, RNU peaked early 2022 and SYR peaked later but SYR was an established producer. I doubt LTP is correcting because of a takeover. It probably is profit taking triggered by the combination of potential delays from a animal toxicology study which may or may not be requested and JFK being appointed which triggered a broader correction in pharmaceuticals. The question now is whether or not the correction is overdone.
TGR, SYR and RNU 5 year charts (graphite and completely unrelated to LTP).
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)